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Human papovavirus JCV is the causative agent of the demyelinating brain disease progressive multifocal leukoencepha-
lopathy (PML) that typically develops as a complication of impaired immunocompetence. JCV displays a strong tropism for
glial cells which is correlated by glial-specific transcriptional regulation of viral gene expression. In a previous report HCMV
was shown to overcome the restricted cell specificity of JCV by inducing DNA replication of a PML-derived JCV strain in
human fibroblasts which are nonpermissive for the replication of JCV alone. Here we show that productive JCV replication
is induced by HCMV in human glioblastoma cells. Both in fibroblasts and in glioblastoma cells, the HCMV immediate-early
transactivator 2 (IE2) is sufficient to mediate JCV replication. Furthermore, IE2 induces DNA replication of several structurally
different brain- or kidney-derived JCV variants. IE2-induced JCV DNA replication is accompanied by the induction of JCV T
antigen expression due to stimulation of the JCV early promoter. Our results indicate that stimulation of JCV early gene
expression by HCMV-IE2 is sufficient to overcome the restricted cell specificity of JCV. © 2000 Academic Press
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Human cytomegalovirus (HCMV), a member of the
herpesvirus group, and the human papovavirus JCV are
structurally unrelated, but share some epidemiological
and pathogenetic features. Both viruses are highly prev-
alent in the adult population, with seropositivity ranging
between 60 and 90% for either of the two viruses (Ho,
1991; Walker and Padgett, 1983). Typically, primary infec-
tion occurs in childhood or in early adulthood and ap-
pears to be asymptomatic in immunocompetent individ-
uals. However, infection with JCV and HCMV results in
lifelong persistence with reactivations typically occurring
upon impaired immunocompetence (Frisque and White,
1992; Ho, 1991; Major et al., 1992). Systemic HCMV in-
ection is manifested in different organs, with HCMV-
nduced retinitis and encephalitis as the most threaten-
ng nervous system complications. JCV is the causative
gent of the demyelinating brain disease progressive
ultifocal leukoencephalopathy (PML), which is charac-
erized by a selective destruction of myelin-forming oli-
odendrocytes. Once a rare disease, the incidence of
ML has risen significantly over the past decades due to
IDS and the introduction of extensive immunosuppres-
ive therapy. Currently, AIDS is the main cause of
teadily increasing numbers of PML cases; 5–10% of
1 To whom correspondence and reprint requests should be ad-
ressed at Institut fu¨r Infektionsmedizin, Abteilung Virologie, UKBF,
reie Universita¨t Berlin, Hindenburgdamm 27, 12203 Berlin, Germany.dax: (49) 30 8445 4485. E-mail: heilbronn@ukbf.fu-berlin.de.
323IDS patients are estimated to develop this life-threat-
ning neurological complication in the end stage of their
isease (Frisque and White, 1992; Major et al., 1992).
JCV displays a highly restricted tissue tropism. In cell
ulture, efficient propagation has been reported for pri-
ary human fetal glial (PHFG) cells and transformed
erivatives thereof (Major et al., 1985; Mandl et al., 1987;
adgett et al., 1971). In humans, JCV DNA was detected
n epithelial cells lining the renal tubules (Chesters et al.,
983; Do¨rries and ter Meulen, 1983; Grinnell et al., 1983;
cCance, 1983), in lymphocytes (Azzi et al., 1996; Do¨r-
ies et al., 1994; Dubois et al., 1996; Houff et al., 1988; Katz
t al., 1994; Major et al., 1990; Monaco et al., 1996;
ieckmann et al., 1994; Schneider and Do¨rries, 1993;
ornatore et al., 1992), and in glial cells (Elsner and
o¨rries, 1992; Ferrante et al., 1995; Major, 1983; Mori et
l., 1992; Quinlivan et al., 1992; White et al., 1992).
hereas lytic infection of oligodendrocytes is being
ade responsible for the neurological symptoms in PML
atients (Walker and Padgett, 1983), lymphocytes may
ct as a reservoir for JCV dissemination and CNS inva-
ion (Gallia et al., 1997; Monaco et al., 1996).
A large number of JCV subtypes have been isolated
ith substantial heterogeneity in their noncoding regu-
atory region. This regulatory region contains the origin
f viral DNA replication and the transcriptional control
egion for early and late viral gene expression (Frisque et
l., 1984). Depending on the structure of the transcrip-
ional control region (TCR), genomic isolates were clas-
ified into three major virus types: TCR class I contains a
uplicated TATA box; TCR class II lacks the distal TATA
0042-6822/00 $35.00
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324 WINKLHOFER ET AL.box and contains an insertion which includes a potential
enhancer core sequence followed by extensively rear-
ranged repeats, whereas the so-called archetype pattern
does not display major repetitions (Do¨rries, 1997; Frisque
and White, 1992; Gallia et al., 1997). Brain-derived JCV
isolates exhibit the TCR class I or class II pattern; kidney-
derived JCV isolates typically show the archetype pat-
tern. Obviously, the control region is responsible for the
pronounced cell tropism of JCV by displaying different
combinations of cell-specific promoter elements (Raj and
Khalili, 1995; Wegner et al., 1993). These findings led to
the hypothesis that rearranged JCV variants emerge from
a persisting archetype which is typically detected in the
kidney, whereas the ability to infect glial cells in the brain
seems to be coupled to the acquisition of glia cell-
specific promoter rearrangements (Ault, 1997; Ault and
Stoner, 1993; Flægstad et al., 1991; Iida et al., 1993;
Loeber and Do¨rries, 1988; Tominaga et al., 1992; Yogo et
al., 1990, 1991, 1994).
We reported previously that HCMV can induce repli-
cation of brain-derived JCV DNA in human fibroblasts
which are entirely nonpermissive for the replication of
JCV alone (Heilbronn et al., 1993). In this report, we show
that HCMV can induce JCV DNA replication of any of the
three JCV TCR classes (TCR class I represented by Mad1,
TCR class II represented by GS/B, and the archetype
represented by GS/K) both in human fibroblasts and in
human glioblastoma cells. We identified the HCMV-im-
mediate-early transactivator 2 (IE2) gene product as the
only HCMV function required to induce JCV T antigen
expression in either cell type. As a consequence, JCV
DNA replication is induced by IE2 irrespective of the JCV
type tested.
RESULTS
HCMV infection induces replication of a brain-derived
JCV strain (GS/B) in human glioblastoma cells
In a recent report HCMV has been shown to induce
JCV DNA replication (strain GS/B) in human diploid fibro-
blasts which are nonpermissive for JCV (Heilbronn et al.,
1993). JCV exhibits a highly restricted tissue tropism with
oligodendrocytes being the main target cells in vivo. In
cell culture, JCV only multiplies efficiently in primary
human fetal glial cells. We therefore asked whether
HCMV can act as a helper virus for JCV DNA replication
in cells of glial origin. HCMV has been shown to replicate
in human glioblastoma cell lines, including U-373 MG
cells, even though its replication is less efficient than in
human fibroblasts (Jault et al., 1994; Poland et al., 1990).
U-373 MG cells were transfected with a cloned brain
variant of JCV (pJCm, strain GS/B) and 16 h later infected
with HCMV (m.o.i. 5 1). Genomic DNA was extracted 3,
5, 7, and 10 days postinfection and the level of JCV DNA
replication was assayed on Southern blots probed with32P-labeled JCV DNA. The JCV band at 5.2 kb represents
eplicated DNA which is resistant to DpnI cleavage. DpnI
egrades unreplicated input JCV DNA visible as low-
olecular-weight bands. As is shown in Fig. 1, HCMV
as able to induce JCV DNA replication in U-373 MG
ells reaching a maximum at 5 days postinfection in
arallel to HCMV DNA replication. The extent of HCMV-
nduced JCV replication lies in the range of that reported
or autonomous JCV replication in PHFG cells (Mandl et
l., 1987).
To test whether full JCV replication has taken place we
nalyzed transfer of infectious virus from U-373 MG cells
o BJAB cells which are fully permissive for JCV but not
CMV. Replication kinetics in BJA-B cells parallel that in
uman fetal glial cells with a latency period of at least 10
ays (Atwood et al., 1992). U-373 MG cells were trans-
ected with 4 mg of covalently closed, circular JCV DNA
derived from pJCm (Heilbronn et al., 1993) and then
infected with HCMV (Fig. 1B). Five days p.i., when HCMV-
induced JCV DNA replication had reached its maximum
(compare with Fig. 1A), cells were cocultivated with
BJA-B cells grown in suspension and only loosely ad-
hered to the underlying monolayer of U-373 MG cells.
When infectious JCV produced in U-373 MG cells infects
BJA-B cells it will initiate a new round of JCV replication.
After 24 h supernatants containing BJA-B cells were
removed and subcultured as a suspension culture for up
to 12 days, when the cells showed cytopathic effects and
started to degenerate. To this time point JCV DNA repli-
cation was detected on Southern blots as a clear JCV
DNA signal of the expected size (5.2 kb). No JCV DNA
replication was observed at days 5 and 9 postcocultiva-
tion (Fig. 1B). This result was reproduced in an indepen-
dent experiment when JCV replication was first detected
11 days after cocultivation (data not shown). Control
hybridization with a probe for HCMV DNA did not detect
any HCMV DNA replication (Fig. 1B). JCV-infected U-373
MG cells had not been carried over or proliferated during
the 12 days in suspension culture. To prove this, we
made use of the typical restriction fragment length poly-
morphism present in B lymphocytes. B cells carry a
rearranged immunoglobulin locus compared to the
germline configuration present in all non-B cells. Rehy-
bridization of the Southern blot with a probe for the
immunoglobulin heavy chain locus (IgH-kappa) differen-
tiated between the germline configuration present in
U-373 MG cells and the rearranged locus in the B cell
line BJA-B (Fig. 1B, bottom). A reappearance of a U-373
MG cell-specific signal was not detected at 12 days
postcocultivation. Therefore, the emerging strong JCV
DNA band can be interpreted as de novo JCV DNA
replication due to transfer of infectious JCV during cocul-
tivation and subsequent JCV replication in permissive
BJA-B cells.
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325HCMV-IE2 INDUCED JCV REPLICATIONHCMV-IE2 but not -IE1 stimulates DNA replication of
JCV strain Mad1
To investigate HCMV functions responsible for the
induction of JCV replication, HCMV-induced JCV DNA
replication was assayed in the presence of 100 mg/ml
FIG. 1. Time course of HCMV-induced JCV replication in human gliobl
(brain variant, subcloned from pJC-GS/B) and 16 h later infected with H
10 days postinfection, cut with EcoRI and DpnI and analyzed on Souther
olecules of 5.2 kb. Bands in the low-molecular-weight range represent
robe as shown in the lower part of the figure. Sensitivity markers were
-373 MG cells were transfected with circularized, vector-free JCV DNA
days p.i. cells were cocultivated with BJA-B cells for 24 h. BJA-B cel
s a suspension culture for another 5, 9, or 12 days as indicated. At the
he Southern blot was first hybridized to 32P-labeled JCV DNA (top). The
the blot was rehybridized with an IgH-chain-specific probe to detect the
EcoRI-digested pJCm (top), cloned HCMV DNA: EcoRI M fragment (mid
respectively (bottom).anciclovir. As expected, HCMV DNA replication was ktrongly inhibited whereas JCV DNA replication did not
how an equivalent degree of reduction (data not
hown). This led us to speculate that HCMV functions
xpressed before HCMV DNA replication were respon-
ible for the observed effect. HCMV-IE gene products are
cells. (A) U-373 MG (5 3 106) cells were transfected with 5 mg of pJCm
train AD169, m.o.i. 5 1). Total genomic DNA was extracted 3, 5, 7, and
. HCMV-induced JCV DNA replication yielded DpnI-resistant unit length
igested plasmid DNA. The blot was rehybridized with a HCMV-specific
pJCm digested with EcoRI or 500 pg with EcoRI/DpnI, respectively. (B)
d from pJCm and then infected with HCMV as described in Fig. 1A. At
removed from the glioblastoma cell monolayer and further cultivated
ted time points genomic DNA was extracted and digested with EcoRI.
s rehybridized with a HCMV-specific probe (middle). In the lower panel
l RFLP which discriminates B cells from non-B cells. Markers are 5 pg
d 5 mg EcoRI-digested genomic DNA of BJA-B cells or U-373 MG cells,astoma
CMV (s
n blots
DpnI-d
50 pg
derive
ls were
indica
blot wa
typica
dle), annown to transactivate a variety of heterologous viral and
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326 WINKLHOFER ET AL.nonviral target promoters including the SV40 promoter
(Biegalke, 1997; Cherrington et al., 1991; Colberg-Poley et
al., 1992; Davis et al., 1987; Everett and Dunlop, 1984;
hazal et al., 1991; Hagemeier et al., 1992; Hermiston et
l., 1987; Pizzorno et al., 1988; Tevethia et al., 1987;
alker et al., 1992; Yoo et al., 1996). We therefore asked
hether HCMV-IEs are responsible for the induction of
CV DNA replication. U-373 MG cells were cotransfected
ith a cloned JCV DNA brain variant (pBKS-Mad1) and
ith plasmids for both HCMV-IE1 and -IE2 (pRR47) or
ither -IE1 or -IE2 alone. HCMV-IE1 and -IE2 expression
evels were controlled by immunofluorescence. Genomic
NA was extracted 6 days after transfection and the
evel of JCV DNA replication was assayed on Southern
lots. As is evident in Fig. 2, both, HCMV infection (lane
) and expression of HCMV-IE2 (lane 5) induced DNA
eplication of JCV strain Mad1 in human glioblastoma
ells. In contrast, HCMV-IE1 alone failed to stimulate JCV
NA replication (lane 4). HCMV-IE1 barely added to the
nducing effect of HCMV-IE2 (lane 3). JCV T antigen
xpression alone is sufficient to induce JCV DNA repli-
ation in U-373 MG cells (lane 7), which is in line with
FIG. 2. JCV DNA replication induced by HCMV-IE gene products.
he experiment was performed as outlined in Fig. 1 with transfec-
ion of 1 mg of cloned JCV brain variant Mad1 (pBKS-Mad1). Different
plasmids (3 mg each) were cotransfected as indicated: pUC19 (lane
); pRR47 (lane 3); pIE1 (lane 4); pIE2 (lane 5). As positive controls
ad1-transfected cells were infected with HCMV 16 h after trans-
ection (lane 6) or cotransfected with pRSV-JCT which constitutively
xpresses JCV T antigen (lane 7). Untransfected U-373 MG cells
lane 8) or untransfected U-373 MG cells infected with HCMV (lane
) served as negative controls. Marker: 50 pg pBKS-Mad1 digested
ith EcoRI (lane 1).ublished data (Feigenbaum et al., 1987). GCMV-IE2 stimulates DNA replication of different JCV
trains in human fibroblasts and glioblastoma cells
In general, JCV brain variants are used for propagation
f JCV in cell culture. Apparently, kidney-derived arche-
ype strains have an even more restricted cell specifity
nd/or replication potential (Daniel et al., 1996). We
herefore asked whether HCMV acts as a helper virus for
oth JCV brain and kidney variants, respectively. Cloned
CV strains Mad1 (pBKS-Mad1), GS/B (pJCm), and GS/K
pJCk) were analyzed by transfection into human fibro-
lasts or into glioblastoma cells with or without a HCMV-
E2 (pIE2) expression construct. In each case, one of two
lates transfected with JCV DNA was infected with
CMV (m.o.i. 5 1) 16 h later. JCV DNA replication was
ssayed 6 days after transfection as described above.
CMV infection as well as cotransfection of HCMV-IE2
ed to DNA replication of all JCV strains, Mad1 (lanes 4
nd 5), GS/B (lanes 7 and 8), or GS/K (lanes 10 and 11),
n both human fibroblasts (Fig. 3A) and human glioblas-
oma cells (Fig. 3B).
CMV-IE2 but not -IE1 induces JCV T antigen
xpression
Based on the result that the presence of JCV T antigen
s sufficient to induce JCV DNA replication (Fig. 2, lane 7)
t is intriguing to speculate that HCMV induces JCV DNA
eplication via HCMV-IE2-mediated expression of JCV T
ntigen. We therefore analyzed T antigen expression on
estern blots with nuclear extracts prepared from U-373
G cells cotransfected with cloned JCV (pBKS-Mad1)
nd expression constructs for HCMV-IE1 and/or -IE2
pIE1 and pIE2, respectively). In parallel, one plate was
ransfected with cloned JCV strain Mad1 and was in-
ected with HCMV (m.o.i. 5 1) 16 h later. As a positive
ontrol, cells were transfected with an expression plas-
id for JCV T antigen (pRSV-JCT). Four days after trans-
ection nuclear extracts were analyzed for JCV T antigen
xpression by Western blotting using a polyclonal rabbit
ntiserum against JCV T antigen (Sock et al., 1996). T
ntigen expression was below detection level upon
ransfection of pBKS-Mad1 alone (Fig. 4, lane 2). How-
ver, both HCMV infection and cotransfection of pIE2
nduced JCV T antigen expression (lanes 5 and 6).
CMV-IE1 alone was not able to induce JCV T antigen
xpression (lane 4) nor was HCMV-IE1 able to influence
he level of JCV T antigen induced upon expression of
CMV-IE2 alone (lanes 3 and 5). Since JCV T antigen
xpression appears to be an obligatory step in HCMV-
nduced JCV DNA replication, HCMV-IE2 should be able
o induce T antigen expression of different PML-type and
rchetype JCV strains. This is indeed the case: As shown
n Fig. 5, HCMV infection as well as HCMV-IE2 expres-
ion induced JCV T antigen expression of all JCV strains
ested, Mad1 (lanes 3 and 4), GS/B (lanes 7 and 8), and
S/K (lanes 11 and 12).
FIG. 3. HCMV-induced DNA replication of PML-type and archetype JCV strains. Human glioblastoma cells, U-373 MG (A), or human fibroblasts (B)
were transfected with cloned JCV (either one of the following strains: pBKS-Mad1; pJCGS/B; pJCGS/K). Cells were either cotransfected with HCMV-IE2
or were superinfected with HCMV 16 h after transfection. Total genomic DNA was extracted 6 days posttransfection and analyzed as described in
Fig. 1.
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328 WINKLHOFER ET AL.HCMV-IE2 transactivates the early JCV promoter
HCMV-IE2 has been shown to transactivate a variety
of heterologous promoters. We therefore assumed that
HCMV-IE2 acts via transactivation of the early JCV pro-
moter. Transient transfection experiments were per-
formed in U-373 MG cells using a reporter plasmid con-
FIG. 4. HCMV-induced JCV T antigen expression of JCV strain Mad1.
Western blot analysis of nuclear extracts prepared from U-373MG cells
with a polyclonal antiserum against JCV T antigen. Cells were trans-
fected with the following plasmids: Lane 1: pRSV-JCT as positive con-
trol, lanes 2 to 6: pBKS-Mad1 (4 mg) each. The following plasmids were
added: pUC19 (lane 2); pRR47 expressing IE1 and IE2 (lane 3); pIE1
(lane 4); pIE2 (lane 5). In lane 6 cells were infected with HCMV infection
16 h after transfection. Untransfected U-373 MG cells served as neg-
ative control (lane 7).
FIG. 5. HCMV-induced JCV T antigen expression of different PML-
type and archetype JCV strains in human glioblastoma cells. Western
blot analysis was performed as in Fig. 4 with nuclear extracts from cells
transfected with the following plasmids: pBKS-Mad1 plus pUC19 (lane
1); pBKS-Mad1 plus pRSV-JCT (lane 2); pBKS-Mad1 plus pIE2 (lane 3);
pBKS-Mad1 plus HCMV infection 16 h after transfection (lane 4); pJCm
(strain GS/B) plus pUC19 (lane 5); pJCm plus pRSV-JCT (lane 6); pJCm
plus pIE2 (lane 7); pJCm plus HCMV infection 16 h after transfection
(lane 8); pJCk (GS/K) plus pUC19 (lane 9); pJCk plus pRSV-JCT (lane 10);
pJCk plus pIE2 (lane 11); pJCk plus HCMV infection 16 h after trans-
fection (lane 12); untransfected U-373 MG cells (lane 13); untransfected
U-373 MG cells infected with HCMV (lane 14).taining the firefly luciferase gene under the control of the
early promoter of JCV strain Mad1 (pGL-Mad1 early)
which was cotransfected with HCMV-pIE1 or -pIE2, re-
spectively. Cell extracts were prepared 48 h after trans-
fection to determine luciferase activities. Cotransfection
of pIE2 resulted in a 23- to 31-fold stimulation of the early
JCV promoter compared to the control without transacti-
vator (pGL-Mad1 early plus pUC19) (Fig. 6A). As ex-
pected, HCMV-IE1 alone had no transactivating proper-
ties. A slightly increased stimulation (40- to 48-fold) was
observed with the combination of HCMV-IE1 and -IE2. In
human fibroblasts the same overall effects were ob-
served, although at a reduced level. HCMV-IE1 in the
absence of -IE2 did not show any transactivating prop-
erties (Fig. 6B). At variance to U-373MG cells we consis-
tently observed that in fibroblasts IE1 added more sig-
nificantly to the effect of IE2. Unfortunately we were
unable to detect T antigen expression in fibroblasts due to
the lower transfection efficiency compared to U-373 MG
cells. Thus we cannot decide whether the observed effect
translates into an enhancement of T antigen expression.
DISCUSSION
In the human organism, polyomavirus JCV only repli-
FIG. 6. Influence of HCMV-IE2 on JCV early gene expression. A
luciferase reporter plasmid carrying the JCV Mad1 regulatory region in
early orientation (pGL-Mad1 early) was transfected in U-373 MG cells
(6A) or in human fibroblasts (6B) with or without expression plasmids
for HCMV-IE1 or -IE2. Luciferase activities in extracts from transfected
cells were determined in two parallel but independent transfections.
Data are represented as fold induction, calculated by comparing values
from cells cotransfected with effector plasmids (pRR47, pIE1, or pIE2) to
values from cells cotransfected with pUC19.cates in a limited number of cells including oligodendro-
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329HCMV-IE2 INDUCED JCV REPLICATIONcytes and B-lymphocytes, where it is detectable by DNA
hybridization or by PCR (Azzi et al., 1996; Do¨rries et al.,
1994; Dubois et al., 1996; Houff et al., 1988; Monaco et al.,
998; Tornatore et al., 1992). The same cell tropism can
e observed in cell culture. Only primary human fetal
lial cells and some human B cell lines including BJAB
ells (Atwood et al., 1992) have been shown to promote
roductive JCV replication. This highly restricted cell tro-
ism of JCV has been attributed to glial-specific tran-
cription factors required for transactivation of the JCV
arly promoter. In a previous report we could show that
uman cytomegalovirus extends the narrow host range
f JCV by inducing JCV DNA replication in nonpermissive
uman fibroblasts (Heilbronn et al., 1993). Here we show
hat HCMV induces productive JCV replication in a glio-
lastoma cell line, U373-MG. In either cell type the effect
s mediated by HCMV-IE2 which leads to JCV T antigen
xpression via transcriptional activation of the JCV early
romoter. In addition, the JCV late promoter is activated
pon HCMV IE gene expression (data not shown). Re-
ently it has been reported that constitutive SV40 T-
ntigen expression in Cos7 cells leads to production of
nfectious JCV archetype strains (Hara et al., 1998). This
s an extension of two early reports that infectious brain-
erived JCV is produced PHFG cells expressing T-anti-
en of SV40 or JCV, respectively (Major et al., 1985;
Mandl et al., 1987). These data taken together imply that
HCMV induces JCV DNA replication by expression of its
major immediate early genes.
HCMV codes for two major immediate-early proteins,
HCMV-IE1 and -IE2, which are expressed from differen-
tially spliced mRNAs transcribed from the well-studied
HCMV major IE enhancer/promoter. Both HCMV-IE1 and
-IE2 have been described as pleiotropic activators
and/or repressors of transcription of a variety of viral and
cellular promoters (Biegalke, 1997; Davis et al., 1987;
Everett and Dunlop, 1984; Ghazal et al., 1991; Hagemeier
et al., 1994; Hagemeier et al., 1992; Hermiston et al., 1987;
Iwamoto et al., 1990; Malone et al., 1990; Pizzorno et al.,
1988; Rando et al., 1990; Stenberg et al., 1990; Tevethia et
al., 1987). While IE2 plays an important role in activating
HCMV early promoters and repressing its own promoter,
IE1 stimulates its own promoter and augments the acti-
vating effect of the IE2 protein on several other promot-
ers (Cherrington and Mokarski, 1989; Hagemeier et al.,
1992; Hermiston et al., 1990; Huang and Stinski, 1995;
Malone et al., 1990; Pizzorno and Hayward, 1990; Piz-
zorno et al., 1991, 1988; Stenberg et al., 1990). IE2 mod-
ulates early gene transcription mainly by protein–protein
interactions. IE2 interacts with itself, with components of
the basal transcription complex, TBP and TFIIB, with the
products of the tumor suppressor genes p53 and pRb,
and with a variety of cellular transcription factors includ-
ing Sp1, Tef-1, c-jun, junB, ATF-2, NF-kB, Erg-1, CREB, and
CBP (Caswell et al., 1993; Chiou et al., 1993; Choi et al.,
1995; Furnari et al., 1993; Hagemeier et al., 1994; Lang etal., 1995; Lang and Stamminger, 1993; Lukac et al., 1994;
Schwartz et al., 1996; Scully et al., 1995; Sommer et al.,
1994; Spector and Tevethia, 1994; Speir et al., 1994; Yoo
et al., 1996). Binding sites for SP1, jun, and CREB have
also been described in the JCV regulatory region which
is suggestive of the mechanism of IE2-induced JCV tran-
scriptional activation (Henson, 1994).
In the experiments presented here HCMV-IE2 alone
strongly induced JCV T antigen expression of archetype
(GS/K) as well as PML-type JCV strains (Mad-1 and
GS/B) via transcriptional transactivation of the JCV early
promoter. IE1 alone had no effect, nor did it modulate
IE2-induced effects, which is in line with findings in other
systems (Cherrington et al., 1991; Lukac et al., 1997;
Malone et al., 1990; Stenberg et al., 1990). The minor,
although consistent, increase in JCV early promoter ac-
tivation by IE1 measured in the luciferase assays ap-
pears to be irrelevant for the observed downstream ef-
fects since it is not reflected by a measurable increase in
T antigen expression nor in JCV DNA replication. JCV T
antigen expression alone has been shown before to be
sufficient for the induction of JCV DNA replication irre-
spective of the JCV strain used (Feigenbaum et al., 1987;
Hara et al., 1998; Mandl et al., 1987; Sock et al., 1996).
These findings taken together conclusively explain
HCMV-induced JCV DNA replication of archetype (GS/K)
as well as PML-type JCV strains (Mad-1, GS/B) in cells
that are nonpermissive for the replication of JCV alone.
JCV T antigen transactivates the viral late promoter
and is involved in the switch from early to late gene
expression during the viral life cycle (Frisque and White,
1992; Khalili et al., 1987; Lashgari et al., 1989). Whereas
for the initiation of JCV DNA replication T antigen binds
directly to the viral origin (Lynch and Frisque, 1990; Tavis
et al., 1994), it seems to modulate late gene expression
indirectly by interacting with several cellular transcription
factors like YB-1 and Tst-1 that bind to the viral late
promoter (Kerr et al., 1994; Renner et al., 1994).
The JCV noncoding region carries the only DNA se-
quence that is highly variable when JCV strains from the
brains of PML patients are compared to kidney-derived
strains from the same patients or from asymptomatic JCV
carriers (Ault and Stoner, 1993; Do¨rries, 1984; Loeber and
Do¨rries, 1988). Brain-derived JCV strains typically carry
extensive and variable rearrangements compared to kid-
ney-derived JCV strains. Typically kidney-derived JCV
strains show very constant DNA sequence patterns
worldwide leading to their designation as archetype
strains. Several reports claimed that in fully permissive
primary human fetal glial cells PML-derived strains rep-
licate more efficiently than archetype strains (Ault, 1997;
Daniel et al., 1996). Recently it has been suggested that
the restricted lytic behavior of archetype JCV relative to
that of rearranged PML-type strains might be due to
specific rearrangements in the promoter–enhancer re-
gion (Daniel et al., 1996). In the presence of JCV T
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330 WINKLHOFER ET AL.antigen, however, the replicative behavior of archetype
and PML-type strains was equivalent in a variety of
primate cell types (Hara et al., 1998; Sock et al., 1996).
pparently, archetype strains are not able to express
dequate levels of T-antigen-specific mRNA to efficiently
upport T-antigen-mediated JCV DNA replication (Daniel
t al., 1996). If this restriction is overcome by constitutive
antigen expression (Hara et al., 1998; Sock et al., 1996)
or by HCMV infection as shown in this report, JCV arche-
type strains replicate as efficiently as PML-derived
strains. In fibroblasts HCMV-IE2-induced transactivation
of the JCV early promoter is consistently lower than in
glial cells even when transfection efficiencies are nor-
malized. These results suggest that in glial cells specific
factors further enhance transcription in addition to the
HCMV-IE2-induced effect. This is in line with the obser-
vation that early and late gene promoters from both
PML-type strains and archetype strains exhibit a signif-
icantly higher activity in glial than in nonglial cells (Sock
et al., 1996). The glial-cell-specific enhancement of
HCMV-induced transactivation was less pronounced in
archetype strains, confirming that PML-type strains are
better adapted to a glial environment.
Taken together, our results suggest that HCMV can
induce JCV replication via IE2-stimulated JCV T antigen
expression. Apparently IE2 alone is sufficient to mediate
this effect. These data are in line with published obser-
vations showing that HCMV infection of human fibro-
blasts enhances DNA replication of cloned SV40 DNA.
HCMV-IE genes have been shown to be responsible for
this effect (Pari and St. Jeor, 1990a,b). Other members of
the herpesvirus family have been shown to activate pa-
povavirus replication. In the case of herpes simplex virus
(HSV) SV40 DNA amplification is induced by a different
mechanism. A subset of HSV replication functions is
required for HSV-induced SV40 DNA amplification and
HSV immediate-early functions are dispensible when the
HSV replication genes are adequately expressed (Heil-
bronn and zur Hausen, 1989). Apparently two herpesvi-
ruses, HCMV and HSV, use different mechanisms to
induce replication of SV40 DNA. This holds true for JCV
as well. In repeated cotransfection experiments with
different combinations of overlapping plasmids and cos-
mids spanning the HCMV genome, no additional HCMV
functions were identified which either replaced or added
to the effect of IE2. In addition, neither HSV infection of
JCV-transfected fibroblasts nor cotransfection of HSV
replication genes ever led to JCV DNA replication (K. W.
and R. H., unpublished observations).
The data presented here clearly show that DNA rep-
lication of HCMV is not required for the induction of JCV
DNA replication. This finding has implications for a pos-
sible interaction of the two viruses in vivo. Both viruses
ypically infect immunocompetent individuals without
igns of disease. Either virus establishes lifelong latency
nd can be reactivated to symptomatic disease in Dhases of impaired immunocompetence. In asymptom-
tic carriers HCMV-IE gene expression can be detected
n a variety of cell types including CD341 hematopoetic
rogenitor cells and myeloid and dendritic progenitor
ells (Mendelson et al., 1996; So¨derberg-Naucler et al.,
997; Taylor-Wiedeman et al., 1991; von Laer et al., 1995).
ymphocytes have been shown to harbor JCV in both
ML patients and healthy individuals (Azzi et al., 1996;
o¨rries et al., 1994; Dubois et al., 1996; Houff et al., 1988;
atz et al., 1994; Major et al., 1990; Monaco et al., 1996;
ieckmann et al., 1994; Schneider and Do¨rries, 1993;
ornatore et al., 1992). This opens the possibility that JCV
nd HCMV interact in vivo in cells harboring both viruses.
estricted HCMV-IE gene expression in the absence of
CMV replication would already be sufficient to stimu-
ate replication of resident JCV. This may be a mecha-
ism of JCV propagation and spread in the body which
ould enhance the probability of subsequent PML de-
elopment.
MATERIALS AND METHODS
ecombinant plasmid DNAs
Cloned JCV DNAs from a PML patient (pJC-GS/B from
rain-derived JCV DNA and pJC-GS/K from kidney-de-
ived JCV DNA) were kindly provided by K. Do¨rries (Loe-
er and Do¨rries, 1988). Subcloning of the JCV DNAs into
he EcoRI site of pBluescript-KS1 (Stratagene) yielded
he plasmids pJCm (brain variant) and pJCk (kidney vari-
nt), respectively. pBKS-Mad1 (Wegner et al., 1993) com-
rises the entire JCV Mad1 genome (5130 bp), linearized
y EcoRI and cloned into pBluescriptIIKS1 (Stratagene).
n all plasmids, the circular JCV genome is disrupted at
he EcoRI site within the late gene region, leaving the
rigin of replication and T antigen intact. Luciferase re-
orter plasmid pGL-Mad1 early (Sock et al., 1996) con-
ains the regulatory region of JCV strain Mad1, map
ositions 5014–273, in early orientation. The expression
ector pRSV-JCT (Sock et al., 1993) contains the coding
egion of JCV T antigen (nucleotide positions 5081–2442)
nder the control of the Rous sarcoma virus LTR. pRR47
as obtained from B. Fleckenstein and comprises the
ntire expression cassette of HCMV immediate early 1
nd 2 (IE1 and IE2) genes (EcoRI–SalI fragment of
CM5018 derived from AD169 cloned into pUC18). Sub-
loning of IE1 (AccI–AccI fragment of pRR47) and IE2
SalI–XhoI fragment of pRR47) into pUC18 yielded pIE1
nd pIE2, respectively.
reparation of covalently closed circular JCV DNA
JCV DNA was separated from vector sequences by
igestion of pJCm with EcoRI and preparative agarose
el electrophoresis. The eluted 5.2-kb JCV DNA band
as recircularized by ligation with T4 DNA ligase at a
NA concentration of 1 to 10 ng/ml. DNA was concen-
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331HCMV-IE2 INDUCED JCV REPLICATIONtrated by repeated extractions with 2-butanol and then
dialyzed. Covalently closed, circular DNA was separated
from unligated DNA by CsCl/ethidium bromide gradient
centrifugation.
Cell culture and viruses
Diploid human fibroblasts were grown at passages 12
to 18 in Dulbecco’s modified Eagle’s medium supple-
mented with antibiotics (1 U/ml penicillin G and 1 mg/ml
streptomycin) and 10% heat-inactivated fetal calf serum.
BJA-B cells were grown in suspension in RPMI medium
with similar supplements. The human glioblastoma cell
line U-373 MG was obtained from the American Type
Culture Collection (ATCC HTB-17) and was maintained in
minimal essential medium with nonessential amino ac-
ids, 1 mM sodium pyruvate, antibiotics (1 U/ml penicillin
G and 1 mg/ml streptomycin), and 10% heat-inactivated
fetal calf serum. HCMV (strain AD169) was propagated
on diploid human fibroblasts. Virus stocks had titers of
1–2 3 106 TCID50/ml.
Transfections
One day before transfection, cells were plated at a
density of 3 3 105 cells/60-mm plate (for Western blot
nalysis and luciferase assays) or 8 3 105 cells/100-mm
plate (for Southern blot analysis) in supplemented me-
dium. Human fibroblasts and U-373 MG cells were either
electroporated as described before (Heilbronn et al.,
1993) or transfected by a liposome-mediated method
(Taylor and Docherty, 1996) using 4–5 mg of plasmid
DNA/60-mm plate. In brief, plasmid DNA was mixed with
25 (U-373 MG) or 50 ml (fibroblasts) liposome stock (1
nmol/ml dioleoyl-L-a-phosphatidylethanolamine (Sigma)
and 1 nmol/ml dimethyldioctadecylammonium bromide
Fluka) and 225 (for U-373 MG cells) or 450 ml (for
fibroblasts) Optimem (Gibco), respectively. After 15 min, 2
ml of Optimem was added and the mixture was poured
onto the rinsed cells. After 6 h at 37°C transfected cells
were washed twice with serum-free medium and grown
in supplemented medium until harvesting.
Southern blot analysis
Six days posttransfection, high-molecular-weight
genomic DNA was extracted from cell nuclei prepared by
SDS/proteinase K (100 mg/ml) digestion for 2 h at 56°C
nd subsequent phenol/chloroform extraction. DNA was
ialyzed against 13 TE overnight. One-half of the puri-
ied DNA was digested with EcoRI and DpnI for 16–20 h,
recipitated, and resuspended in 40 ml 13 TE. Digestion
ith EcoRI releases JCV DNA from vector sequences so
hat linear JCV DNA is visible as the unit-length molecule
f 5.2 kb. DpnI selectively digests transfected plasmid
NA which has been N6A-methylated during prokaryotic
eplication, whereas DNA replicated in eukaryotic cells
acks N6A-methylation and becomes resistant to DpnI.igested DNA at 5 mg/lane was run on 0.8% agarose
els and blotted onto nylon membranes (Gene Sreen
lus, Dupont). Blots were UV cross-linked and hybridized
s described elsewhere (Church and Gilbert, 1984).
riefly, nylon membranes were prehybridized in Genomic
ix (1% bovine serum albumine fraction V; 1 mM EDTA,
H 8.0; 0.5 M sodium phosphate buffer, pH 7.2; 7% SDS)
or at least 1 h at 68°C, hybridized in Genomic Mix
vernight at 68°C using 32P-labeled vector-free JCV DNA
as a probe (Feinberg and Vogelstein, 1983), washed with
Genomic Wash (1 mM EDTA, pH 8.0; 40 mM sodium
phosphate buffer, pH 7.2; 1% SDS), and exposed to X-ray
films.
Preparations of nuclear extracts
Nuclear extracts were prepared from U-373 MG
cells 4 days after transfection as described elsewhere
(Schreiber et al., 1989). Briefly, cells from a 60-mm plate
were washed twice with phosphate-buffered saline,
scraped from the plates, resuspended in buffer A (10 mM
HEPES (N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic
acid), pH 7.9; 10 mM KCl; 0.1 mM EDTA; 0.1 mM EGTA
[ethylene glycol-bis(b-aminoethyl ether)-N,N,N9,N9-tet-
aacetic acid]; 2 mM dithiothreitol; 10 mg/ml leupeptin–10
mg/ml aprotinin), swollen on ice, and lysed by the addi-
tion of 1% Nonidet P-40 and vortexing. Nuclei were pel-
leted and extracted in 75 ml of ice-cold buffer B (buffer A
plus 400 mM NaCl; 1% Nonidet P-40) for 15 min at 4°C
under constant rotation.
Western blot analysis
A 10-ml volume of nuclear extract was size fractionated
n a SDS–polyacrylamide gel (8%) and transferred to
itrocellulose membranes. The nitrocellulose filters were
locked with 6% nonfat milk in PBST (PBS containing
.1% Tween 20) overnight at 4°C. After being rinsed with
BST, the membranes were incubated for 1 h at room
emperature with polyclonal anti-JCT antigen antiserum
Sock et al., 1996), diluted 1:3000 in PBST. Following
hree washes with PBST, the membranes were incubated
or 20 min at room temperature with horseradish-perox-
dase-coupled goat anti-rabbit antibodies (1:3000) in
BST. After extensive washing, T antigen was detected
ith the enhanced chemiluminescence detection system
Amersham) as specified by the manufacturer.
uciferase assays
In general, 1 mg of reporter plasmid was cotransfected
ith 3 mg of effector plasmid into U-373 MG cells or
human fibroblasts. After 48 h cells were harvested and
assayed for luciferase activity with the luciferase assay
system (Promega) as specified by the manufacturer. To
minimize the influence of transfection efficiencies on the
outcome of the experiments, all transfections were per-
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332 WINKLHOFER ET AL.formed repeatedly with different plasmid preparations
and in duplicate.
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